CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-16 | Pourhassan Nader President and CEO | Grant or award · Stock Options (right to buy) | +500,000 | 500,000 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Grant or award · Stock Options (right to buy) | +54,545 | 54,545 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Grant or award · Stock Options (right to buy) | +200,000 | 200,000 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Grant or award · Stock Options (right to buy) | +650,000 | 650,000 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Grant or award · Stock Options (right to buy) | +304,000 | 304,000 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Grant or award · Stock Options (right to buy) | +600,000 | 600,000 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Grant or award · Stock Options (right to buy) | +300,000 | 300,000 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Grant or award · Stock Options (right to buy) | +600,000 | 600,000 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Grant or award · Stock Options (right to buy) | +350,000 | 350,000 | ||
| 2018-11-16 | Pourhassan Nader President and CEO | Grant or award · Stock Options (right to buy) | +1,000,000 | 1,000,000 | ||
| 2018-11-16 | Naydenov Jordan G Director | Grant or award | +5,304,490 | 5,304,490 | ||
| 2018-11-16 | Naydenov Jordan G Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2018-11-16 | Naydenov Jordan G Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2018-11-16 | Naydenov Jordan G Director | Grant or award · Stock Options (right to buy) | +25,000 | 25,000 | ||
| 2018-11-16 | Naydenov Jordan G Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2018-11-16 | Naydenov Jordan G Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2018-11-16 | Naydenov Jordan G Director | Grant or award · Stock Options (right to buy) | +75,000 | 75,000 | ||
| 2018-11-16 | Naydenov Jordan G Director | Grant or award · Stock Options (right to buy) | +96,397 | 96,397 | ||
| 2018-11-16 | Naydenov Jordan G Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2018-11-16 | Naydenov Jordan G Director | Grant or award · Stock Options (right to buy) | +100,000 | 100,000 |
Page 23 of 33 · 652 trades